Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes

Biochemical and Biophysical Research Communications

Volumn 414, Issue 3, 2011, Pages 635-640

  Inoh, Yoshikazu ^a   Furuno, Tadahide ^a   Hirashima, Naohide ^b   Kitamoto, Dai ^c   Nakanishi, Mamoru ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Biosurfactants; Cationic liposome; Gene transfection; SiRNA

Indexed keywords

BIOSURFACTANT; LIPID; LIPOFECTAMINE; MANNOSYLERYTHRITOL LIPID A; OLIGONUCLEOTIDE; PLASMID DNA; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSPORT; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; CYTOTOXICITY; ENDOCYTOSIS; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; INTRACELLULAR SIGNALING; LIPOSOMAL GENE DELIVERY SYSTEM; MEMBRANE FUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; CYTOPLASM; GENE THERAPY; GLYCOLIPIDS; LIPID A; LIPOSOMES; MELANOMA, EXPERIMENTAL; MEMBRANE FUSION; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; SURFACE-ACTIVE AGENTS; TRANSFECTION;

EID: 80054892823     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.147     Document Type: Article

References (34)

1. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
2. Sen G.L., Blau H.M. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol. 2005, 7:633-636.
3. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 2004, 15:185-197.
4. Meade B.R., Dowdy S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev. 2008, 60:530-536.
5. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-438.
6. Zender L., Hutker S., Liedtke C., Tillmann H.L., Zender S., Mundt B., Waltemathe M., Gosling T., Flemming P., Malek N.P., Trautwein C., Manns M.P., Kuhnel F., Kubicka S. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl Acad. Sci. USA 2003, 100:7797-7802.
7. Poeck H., et al. 5'-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat. Med. 2008, 14:1256-1263.
8. Akhtar S., Benter I.F. Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 2007, 17:3623-3632.
9. Brantl S. Antisense-RNA regulation and RNA interference. Biochim. Biophys. Acta 2002, 1575:15-25.
10. Chiu Y.L., Ali A., Chu C.Y., Cao H., Rana T.M. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol. 2004, 11:1165-1175.
11. Kogure K., Akita H., Yamada Y., Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv. Drug Deliv. Rev. 2008, 60:559-571.
12. Han S.E., Kang H., Shim G.Y., Suh M.S., Kim S.J., Kim J.S., Oh Y.K. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int. J. Pharm. 2008, 353:260-269.
13. Negishi Y., Endo Y., Fukuyama T., Suzuki R., Takizawa T., Omata D., Maruyama K., Aramaki Y. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J. Controlled Release 2008, 132:124-130.
14. Kim H.K., Davaa E., Myung C.S., Park J.S. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int. J. Pharm. 2010, 392:141-147.
15. Segura T., Hubbell J.A. Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. Bioconjug. Chem. 2007, 18:736-745.
16. Ladewig K., Nibert M., Xu Z.P., Gray P.P., Lu G.Q.M. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles. Biomaterials 2010, 31:1821-1829.
17. Kitamoto D., Yanagishita H., Shinbo T., Nakane T., Nakahara T., Kamisawa C. Surface active properties and antimicrobial activities of mannosylerythritol lipids as biosurfactants produced by Candida Antarctica. J. Biotechnol. 1993, 29:91-96.
18. Isoda H., Shimamoto H., Kitamoto D., Matsumura M., Nakahara T. Differentiation of human promyelocytic leukemia cell line HL60 by microbial extracellular glycolipids. Lipids 1997, 32:263-271.
19. Wakamatsu Y., Zhao X., Jin C., Day N., Shibahara M., Nomura N., Nakahara T., Murata T., Yokoyama K.K. Mannosylerythritol lipid induces characteristics of neuronal differentiation in PC12 cells through an ERK-related signal cascade. Eur. J. Biochem. 2001, 268:374-383.
20. Inoh Y., Kitamoto D., Hirashima N., Nakanishi M. Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes. Biochem. Biophys. Res. Commun. 2001, 289:57-61.
21. Inoh Y., Kitamoto D., Hirashima N., Nakanishi M. Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion. J. Controlled Release 2004, 94:423-431.
22. Ueno Y., Inoh Y., Furuno T., Hirashima N., Kitamoto D., Nakanishi M. NBD-conjugated biosurfactant (MEL-A) shows a new pathway for transfection. J. Controlled Release 2007, 123:247-253.
23. Noguchi S., Furuno T., Hirashima N., Nakanishi M. Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotides. J. Controlled Release 2003, 88:313-320.
24. Gao X., Jaffurs D., Robbins P.D., Huang L. A sustained cytoplasmic transgene expression system delivered by cationic liposomes. Biochem. Biophys. Res. Commun. 1994, 200:1201-1206.
25. Romøren K., Thu B.J., Bols N.C., Evensen Ø. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. Biochim. Biophys. Acta 2004, 1663:127-134.
26. Iwaoka S., Nakamura T., Takano S., Tsuchiya S., Aramaki Y. Cationic liposomes induce apoptosis through p38 MAP kinase-caspase-8-Bid pathway in macrophage-like RAW264.7 cells. J. Leukoc. Biol. 2006, 79:184-191.
27. Keller M. Lipidic carriers of RNA/DNA oligonucleotides and polynucleotides: what a difference a formation makes!. J. Controlled Release 2005, 103:537-540.
28. Wong A.W., Scales S.J., Reilly D.E. DNA internalized via caveolae requires microtubule-dependent, rab7-independent transport to the late endocytic pathway for delivery to the nucleus. J. Biol. Chem. 2007, 282:22953-22963.
29. Dominska M., Dykxhoorn D.M. Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 2010, 123:1183-1189.
30. Harashima H., Shinohara Y., Kiwada H. Intracellular control of gene trafficking using liposomes as drug carriers. Eur. J. Pharm. Sci. 2001, 13:85-89.
31. Carmona S., Jorgensen M.R., Kolli S., Crowther C., Salazar F.H., Marion P.L., Fujino M., Natori Y., Thanou M., Arbuthnot P., Miller A.D. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. Mol. Pharm. 2009, 6:706-717.
32. Richards Grayson A.C., Doody A.M., Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 2006, 23:1868-1876.
33. Wang X.L., Xu R., Lu Z.R. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. J. Controlled Release 2009, 134:207-213.
34. Sioud M. RNA interference and innate immunity. Adv. Drug Deliv. Rev. 2007, 59:153-163.